Premium
Drugs for Children
Author(s) -
Ito S
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.675
Subject(s) - clinical pharmacology , medicine , orphan drug , safer , global health , drug , population , intensive care medicine , pharmacology , environmental health , public health , bioinformatics , biology , pathology , computer security , computer science
The “Therapeutic Orphan” status of children is gradually improving, but our efforts to eliminate off‐label/off‐evidence use must be sustained for safer and more effective pediatric drug therapy. This is even more important in resource‐scarce settings, because of the increasing child population in those regions. The juncture of pediatric pharmacology and global child health represents an emerging field of clinical pharmacology illuminating a crucial societal need on a global scale.